Meaidi A

No ORCID on file · 7 papers in corpus · active 2021-2026

Study types

  • other 2

Condition tags

  • endometriosis 2
  • infertility 2
  • dysmenorrhea 1
2026
PLoS medicine ·doi:10.1371/journal.pmed.1004652

BackgroundSex hormones have been implicated in leukemogenesis, but evidence regarding hormonal contraceptive use and leukemia risk remains limited and primarily based on older formulations. Given the widespread use of contemporary hormonal …

2025
JAMA ·doi:10.1001/jama.2024.28778
other 2025
American journal of ophthalmology ·doi:10.1016/j.ajo.2025.05.027

PURPOSE: To investigate the association between hormonal contraceptive use and the risk of retinal vascular occlusions in women of reproductive age. DESIGN: Register-based, nationwide cohort study. PARTICIPANTS: A total of 2,208,172 women…

2024
JAMA ·doi:10.1001/jama.2024.18575
other 2024
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2023.100813

BACKGROUND: Use of the high-dose levonorgestrel-releasing intrauterine system (LNG-IUS) has been associated with increased risk of incident depression. Evidence is lacking on the influence of use of two recently marketed low-dose LNG-IUS on…

2023
JAMA ·doi:10.1001/jama.2023.0380
2021
EClinicalMedicine ·doi:10.1016/j.eclinm.2021.100882

BackgroundOral tranexamic acid is effective for heavy menstrual bleeding, but the thrombosis risk with this treatment is largely not studied.MethodsUsing nationwide registries, we assessed associations between use of oral tranexamic acid an…